title: Transport of alpha-ketoisocaproate in rat cerebral cortical neurons.
abstract: Transport of alpha-ketoisocaproic acid (KIC), the product of leucine transamination, was studied in the cerebral cortex cells isolated from the adult rat brain. The process of [(14)C]KIC accumulation was followed in the presence of aminooxyacetate, an inhibitor of transaminases. Accumulation of KIC was not affected by Na(+) replacement, its initial velocity was observed to be higher upon lowering of external pH. Addition of KIC promoted acidification of cytoplasmic pH, monitored with 2'7'-bis(carboxyethyl)-5(6)-carboxyfluorescein. The detected inhibition of KIC accumulation by alpha-cyano-4(OH)cinnamate pointed to an involvement of one of monocarboxylate transporters (MCT), although 4,4'-diisothiocyano-2,2'-stilbenedisulphonate was without effect. Accumulation of KIC was inhibited by lactate; the effect of pyruvate was detected to be much weaker. Other branched-chain alpha-ketoacids (ketoisovalerate, keto-methylvalerate), as well as beta-hydroxybutyrate and valproate decreased the transport of KIC by 30, 60, and 80%, respectively. The observed characteristics of KIC accumulation in the cortical neurons indicate an involvement of one of the MCT transporters. A crucial role of SH group(s) in the process of KIC accumulation, excluding MCT2, indicates the MCT1, although an involvement of another isoform of MCT in the process of KIC transport in neurons from cerebral cortex of adult brain has not been definitely excluded.
authors.affiliation: Department of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology, Pasteur Street 3, Warsaw, 02-093, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Mac
authors.forename: A
authors.initials: A
authors.lastname: Nehlig
authors.forename: M J
authors.initials: MJ
authors.lastname: Nałecz
authors.forename: K A
authors.initials: KA
authors.lastname: Nałecz
mesh_terms: D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002264:Carboxylic Acids / Q000494:pharmacology; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology* / Q000378:metabolism; D003373:Coumaric Acids / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007651:Keto Acids / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D027501:Monocarboxylic Acid Transporters; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D020033:Protein Isoforms / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D000637:Transaminases / Q000037:antagonists & inhibitors / Q000378:metabolism; D020245:p-Chloromercuribenzoic Acid / Q000494:pharmacology
chemical_list: D002264:Carboxylic Acids; D002352:Carrier Proteins; D003373:Coumaric Acids; D007651:Keto Acids; D027501:Monocarboxylic Acid Transporters; D020033:Protein Isoforms; D013439:Sulfhydryl Reagents; D000625:Aminooxyacetic Acid; C007175:alpha-cyano-4-hydroxycinnamate; D020245:p-Chloromercuribenzoic Acid; C013082:alpha-ketoisocaproic acid; D000637:Transaminases; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid